Chicago, IL – According to filings with the U.S. Securities and Exchange Commission, CancerIQ is raising $2,565,700.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Olufeyikemi Ayodele played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About CancerIQ

CancerIQ helps providers use genetic information to predict, pre-empt, and prevent disease – starting with cancer. By making is easier to identify patients at risk, offer a genetic evaluation at point of care, and design a tailored cancer prevention plan – we can help healthcare systems get ahead of this costly and emotionally devastating disease.

To learn more about CancerIQ, visit http://www.canceriq.com/

Contact:
Olufeyikemi Ayodele, Chief Executive Officer
312-761-3360
https://www.linkedin.com/in/feyiolopade/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved